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Background: The search for the perfect insufﬂating gas has been elusive. Even though Carbon dioxide
(CO2) is the most commonly used gas, it has numerous cardiovascular, respiratory and hemodynamic
side effects, which have often been taken for granted. In the current scenario of ever expanding and
complex indications for Laparoscopic Surgery these changes have an increasing implication of placing the
patient at risk. Nitrous Oxide (N2O) has now made a comeback and shown by recent studies to be as safe
as CO2 for creating pneumoperitoneum (PP). The purpose of our study is to determine whether beneﬁts
of N2O (PP) outweigh those of CO2 PP in Laparoscopic Surgery.
Material and methods: All patients undergoing Laparoscopic Surgery over an 8 week period were divided
into two groups. Data were collected prospectively for Group I {N2O(n ¼ 38)} and Group II {CO2 PP
(n ¼ 39)}. Heart rate, Mean Arterial Blood Pressure, End-Tidal CO2, Arterial pH, Peak Airway Pressure,
Minute Ventilation and O2 Saturation were recorded before PP, 15 minutes after PP and 10 minutes after
exsufﬂation. Intraoperative anesthetic agent and postoperative pain medication use was recorded. Pain
was assessed by means of visual analog scale (VAS) at postoperative hours 2 and 4 and on day1. Results
tabulated and analyzed statistically.
Results: There was no statistical difference in age, sex, weight, complexity of surgery (type of procedure
and duration of PP), Anesthetic risk, and duration of hospitalization between the two groups. Mean End-
Tidal CO2 increase was greater despite a greater mean intraoperative increase in Minute Ventilation in
group II, Heart Rate, Arterial pH, Mean Arterial Pressure under anesthesia were signiﬁcantly higher in
group II. The quantum of intraoperative anesthetic agent and postoperative pain (as assessed by Visual
Analog Scale) was less in group I.
Conclusion: This is an initial study assessing the use of N2O for insufﬂation; the results of our study
suggest N2O PP has a deﬁnitive advantage over CO2 PP. Further multicentric randomized trials are
necessary before N2O becomes the standard insufﬂating agent.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Carbon dioxide (CO2) is presently the universally used agent for
creating a pneumoperitoneum (PP). It is inexpensive, highly soluble
in blood, rapidly eliminated, and suppresses combustion.1,2 It does,
however, possess metabolic, hemodynamic, and cardiovascular
adverse effects such as hypercarbia, acidosis, peritoneal irritation
and cardiac arrhythmias.3e6 These complex physiological adjust-
ments associated with CO2 PP are often ignored in Laparoscopic
surgery. Although these conditions may be tolerated in healthyRammohan).
ciates Ltd. Published by Elsevier Ltindividuals, the elderly and patients with preexisting medical
conditions may be placed at greater peril.3e8
Prior to the use of CO2, N2Owas the preferred gas for PP.9e12 N2O
shares several advantages with CO2. It is also inexpensive, readily
absorbed, and rapidly eliminated from the body. It also has anes-
thetic and analgesic properties, without the hemodynamic side
effects of CO2.8,13e15 Even though it does not support combustion it
does not suppress combustion.13 This theoretical fear of combus-
tion, a misunderstanding of the physical chemistry of nitrous oxide,
and two anecdotal case reports of intraperitoneal explosions during
female sterilization procedures led to a rapid decline in its use in
laparoscopy.16,17 N2O has now made a comeback and shown by
recent clinical and experimental studies to be as safe as CO2 for
creating PP.10e13,18e20d. All rights reserved.
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Pre and perioperative characteristics of the study population.
Variable N2O(n ¼ 38) CO2(n ¼ 39) p Value
Age (years, range) 47(25e69) 48(28e68) NS
Sex (male/female) 20/18 22/17 NS
Weight (Kg) 67.6  14.5 68.7  10.0 NS
Duration of pneumoperitoneum (min) 52.1  22 51.9  23.7 NS
Anesthetic risk (ASA > 2) 4(10.5%) 4(10.2%) NS
Duration of hospitalization (days) 1.6  0.6 1.7  0.7 NS
Changes in heart rate and mean arterial pressure (MAP) during N2O and CO2
insufﬂation (difference in mean values before and during PP).
Parameters N2O(n ¼ 38) CO2(n ¼ 39) p Value
DHeart rate (beats/min) 3  6.7 8.4  9.1 p < 0.01
DMean arterial pressure (mmHg) 5.0  10.8 12.1  11.8 p < 0.01
Arterial pH during N2O and CO2 insufﬂation.
pH N2O CO2 p Value
Before PP 7.44  0.04 7.43  0.05 NS
15 min of PP 7.41  0.03 7.38  0.03 p < 0.01
Just before exsufﬂation 7.40  0.04 7.36  0.04 p < 0.01
Mean end tidal CO2 (mmHg) values during N2O and CO2 insufﬂation.
Mean EtCO2 N2O CO2 p Value
Before PP 31.6 32 NS
15 min of PP 32 36.8 p < 0.01
Just before exsufﬂation 31.2 37.6 p < 0.01
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A. Rammohan et al. / International Journal of Surgery 9 (2011) 173e176174With this ever increasing body of evidence stacking in favor of
N2O, we decided to reconsider and evaluate the efﬁcacy of N2O as
an agent for PP. The aim of this prospective, single blind, clinical
trial was to determine whether beneﬁts of N2O PP outweigh those
of CO2 PP in Laparoscopic Surgery.
2. Material and methods
Following an approval from the ethics committee and an informed consent from
the patients, all patients over the age of 21 who were undergoing laparoscopic
surgery at our hospital were offered the opportunity to participate in this trial. Over
an 8 week period fromMarch to May 2009, Seventy seven consecutive patients who
presented to the hospital were divided into two groups Group I {N2O (n ¼ 38)} and
Group II {CO2 (n ¼ 39)}.
The Anesthesiologists were blinded to the PP gas used. Patients were pre-
medicated with Lorazepam 2 mg orally 6 h before surgery. Intravenous Inj. Glyco-
pyrrolate 0.2 mg was administered at the time of induction. Anesthesia was induced
with 2 mg/kg Propofol with 2 ml of 2% plain lignocaine (without preservative) in the
same syringe, 4 mg/kg Inj. Fentanyl and 0.5 mg/kg Atracurium (muscle relaxant)
were also given for intubation and 10 mg of Atracurium was repeated at 30 min
intervals. Patient was ventilated with bag and mask for 3 min and intubated with
a suitably sized endotracheal tube. Anesthesia was maintained with Isoﬂurane 1% in
an oxygen/air mixture (inspired oxygen concentration 50%). Enough isoﬂurane was
delivered for the patient to tolerate the surgery, the efﬁcacy being assessed by the
blood pressure, heart rate and possible movements of the patient. If the patient
showed signs of too light anesthesia, the inspiratory isoﬂurane concentration was
increased with increments of 0.5 vol%. The patients were ventilated in a respirator,
ventilation being adjusted to normoventilation by capnometry. At the end of the
procedure, the muscle relaxation was reversed with 2.5 mg Neostigmine combined
with 0.5 mg Glycopyrrolate.
Heart rate, Blood pressure from the radial artery, pulse oximetry, and capn-
ometry (end expiratory [ET] CO2 concentration) were monitored continuously
during the operation (Aestiva 5, Datex-Ohmeda, India). Arterial blood samples were
obtained during the procedure to analyze blood pH, PO2, and PaCO2. The end
expiratory gas isoﬂurane concentration was recorded by an anesthetic gas meter (S-
5 Datex-Ohmeda, India). The isoﬂurane consumption to maintain the lowest
possible anesthesia level was calculated as minimal alveolar concentration (MAC)-
hours{MAC-h}, recording the isoﬂurane concentrations which the patient needed;
1.15% was used as the isoﬂurane MAC value.21 Baseline values of the above param-
eters before commencement of operation, follow-up values at 15 min after
commencing PP and just before exsufﬂation were recorded.
During the procedure, intra-abdominal pressure was maintained automatically
at 12e14 mm Hg by an insufﬂator (Karl Storz Endoscopy India Private Ltd).
Monopolar electrosurgery and/or ultrasonic dissection (harmonic scalpel) were
used in all operations.
After the operation, patients received an initial bolus of 100 mg Tramadol
intramuscularly, with subsequent doses of 50 mg 4e6th hourly (upto a maximum
total dose of 400 mg) depending on discretion of the nurse or the request of the
patient. Intravenous Diclofenac (1 mg/kg) was also used at the judgment of the
nurse. Once Oral feeds were started, patients were switched to oral analgesics
tablets (37.5 mg Tramadol þ 375 mg Acetaminophen). Total analgesic consumption
was recorded. The intensity of postoperative pain was assessed by the patients
themselves using a visual analog scale for pain scoring (on a 0e10 scale) at post-
operative hours 2, 4 and 24.
For statistical analysis, the Student’s t-test, chi-square test, and the Man-
neWhitney U test for nonparametric data were performed. A p value <0.05 was
considered to represent a statistically signiﬁcant difference between groups.
3. Results
In our study there were a total of 77 patients. 38 in the N2O
group 39 in the group which received CO2 for PP. The two groups
were well matched with respect to demographic information (age,
sex, and weight), complexity of surgery (type of procedure and
duration of PP), Anesthetic risk, and duration of hospitalization.Distribution of laparoscopic procedures.
Procedure N2O (n ¼ 38) CO2 (n ¼ 39)
Cholecystectomy 15 16
Appendectomy 12 11
Inguinal hernia repair 5 7
Ventral hernia repair 6 5Therewas a signiﬁcant difference between N2O and CO2 groups
in the intraoperative heart rate changes, mean arterial pressure
(MAP) changes during PP, the CO2 group showing a substantial rise
in heart rate and MAP as compared to the N2O group.During CO2 insufﬂation, therewas signiﬁcant respiratory acidosis,
as assessed by means of ETCO2 and pH monitoring during the
procedure. In the group receiving CO2 for PP, there was a signiﬁcant
increase in ETCO2 concentrations despite a concurrent increase in the
minute ventilation. There was a substantial fall in the arterial pH for
thepatients inCO2group. Thesephenomenawerenotobserved in the
N2O group.0
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Mean minute ventilation (L/min) values during N2O and CO2 insufﬂation.
Mean minute ventilation N2O CO2 p Value
Before PP 5.7 5.8 NS
15 min of PP 5.4 6.6 p < 0.01
Just before exsufﬂation 5.5 6.9 p < 0.01
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procedure was signiﬁcantly lower in the N2O (0.67 MAC-h) than in
the CO2 group (0.8 MAC-h).Total amount of anesthetic (MAC-h) needed in the N2O and CO2 groups.
N2O CO2 p Value
Isoﬂurane MAC-h 0.67 0.8 p < 0.05
0.6
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Isoflurane MAC-h
N20
CO2The total analgesic consumptionwas lower in the N2O group but
this difference was not statistically signiﬁcant. Despite receiving
a similar quantum of pain relief, the patients in the N2O group had
signiﬁcantly less pain than patients in the CO2 group at 2 h, 4 h and
24 h postoperatively.Postoperative analgesic medication (mg) needed in the N2O and CO2 groups.
Analgesic N2O CO2 p Value
Tramadol (IM þ oral) 146.2  26.8 158.2  37.4 NS
Diclofenac (IV) 102.4  10.9 110.6  10.4 NS
Acetaminophen (oral) 578  110 624  127 NS
Visual analogue pain scores in patients in hours at 2, 4 and 24 h of N2O PP and CO2 PP.
Hours N2O CO2 p Value
2 5.1 6.3 p < 0.05
4 3.6 5.9 p < 0.01
24 1.9 3.7 p < 0.014. Discussion
This is an initial study assessing the use of N2O for insufﬂation;
the results of our study suggest N2O PP has a deﬁnitive advantage
over CO2 PP.
Patients who received N2O for insufﬂation had lower pain scores
on the visual analog scale, this was despite the consumption of
analgesics being similar in both groups, or even tended to be lower in
theN2Ogroup. These results are in accordancewith thoseof previous
studies.8,14,15,22 Two studies assessed pain associatedwith diagnostic
laparoscopy under local anesthesia.8,22 Both studies were random-
ized and double blind, both studies demonstrated less postoperative
discomfort with N2O than with CO2. However, in these studies,
patients underwent only diagnostic laparoscopy under local anes-
thesia; the patient groups were heterogeneous with regard to their
basic illnesses and inoneof the studiespainwasassessedbyarbitrary
scoring.22 Aitola et al. in their prospective randomized study of 40
patients compared N2O and CO2 PP during laparoscopic cholecys-
tectomy.15 They showed that N2O PP produced less postoperative
pain and required a decreased quantity of anesthetic for the surgical
procedure than did CO2 PP. More recently, Tsereteli et al. in their
prospective randomized clinical trial comparing N2O and CO2 PP
during upper gastrointestinal laparoscopic surgery have shown that
postoperative pain is less with N2O PP thanwith CO2 PP.14
The mechanism underlying the favorable analgesic effect of N2O
is not exactly known. There are several postulates. Phillips et al.
suggested that the improved tolerance to N2O must be due to local
effects, because they found no signiﬁcant levels of absorbed and
expired N2O during or after the procedure.23 CO2 may transform
into carbonic acid by combining with ﬂuid in the peritoneal cavity,
which in turn acts a peritoneal irritant.24
In our study we were able to show a reduced amount of anes-
thetic was needed for patients in the N2O group. This is in concur-
rence with other studies.14,15 The reason behind this phenomenon
could be due to the lack of local irritation by N2O and a favorable
effect on the central nervous system (CNS), whichwould then result
in an advantageous interaction with an anesthetic. A higher anes-
thetic requirement in the CO2 group might be due to the increased
sympathetic activity due to respiratory acidosis, which in turn
necessitates an increased administration of anesthetic to keep the
patient hemodynamically stable.25e27
Even thoughCO2 is themost commonly used gas, it has numerous
cardiovascular, respiratory and hemodynamic side effects. Compli-
cations include hypercarbia, acidosis, tachycardia, decreased stroke
volume; arrhythmias, hyperventilation-induced barotrauma, oli-
guria, increased intracranial pressure, and peritoneal irritability.
These have often been taken for granted. In the current scenario of
ever expanding and complex indications for Laparoscopic Surgery
these changes have an increasing implication of placing the older and
less healthy patient at risk.4e8,13,14
The main concern arising from the use of CO2 as pneumo-
peritoneum gas has been the development of hypercarbia and
A. Rammohan et al. / International Journal of Surgery 9 (2011) 173e176176respiratoryacidosis.6,7 Inpatientswithanormalphysiologicalproﬁle,
this can be compensated for by increasing ventilation, but inpatients
with cardio-respiratory compromise, compensation is not always
possible. In such cases, conversion from CO2 to N2O has been found
useful.13,26 Hunter et al. in a large animal study demonstrated that
end-tidal CO2measurementmay signiﬁcantly underestimate arterial
pCO2, and this difference ismagniﬁedwhena rapid ventilatory rate is
required to compensate for respiratory acidosis. The same study
suggested that fetal acidosis developed in pregnant ewe model
receiving CO2 pneumoperitoneum.20 A study by Gardner et al.
recommendsnitrous oxide as the primary insufﬂation gas inpatients
with respiratory compromise.26
The main theoretic concern related to the use of N2O is its
inability to suppress combustion. N2O is not combustible, but in the
presence of a volatile gas, such as hydrogen or methane, N2O is an
oxidizer with properties similar to room air.11e13
N2O was the preferred gas for pneumoperitoneum in the
1970se80s. This was until it received ignominy based on two
unsubstantiated case reports, one from Sri Lanka and the other
fromEgypt.16,17 In both cases, combustion apparently occurred after
all electrical current had ceased. So it is unlikely that these cases
represent N2O induced/supported ignition. But it is unlikely that we
will know what really happened in those two scenarios and it
seems most unreasonable to implicate N2O.
An increasing body of literature (physical chemistry andmedical),
have demonstrated the safety of N2O.10e13,18e20 Several studies have
demonstrated that even without bowel preparation, methane and
hydrogen were undetectable in the pneumoperitoneum of patients
undergoing laparoscopic cholecystectomy.11e13,27 It is theoretically
possible for an accidental electrosurgical colonic perforation in
a methane- or hydrogen-ﬁlled colon to ignite in N2O PP.12 Hydrogen
and methane are produced only in the colon by the normal bacterial
ﬂora. Assuming the highest reported incidence of accidental colon
injury (1 in 2000) and the requirements for large concentrations of
hydrogen and methane to cause combustion, it is no surprise that
many hundreds of laparoscopic gynecological procedures have been
performed in an N2O environment with electrosurgery without
a single episode of combustion.29e31
In early colonoscopic polypectomy cases, due to the fear of
combustion the colon was insufﬂated with CO2. This fear of
combustion was found to be theoretical and CO2 was abandoned in
favor of air to simplify insufﬂation. In a similar vein it seems
unreasonable to condemn N2O PP.
A second potential disadvantage of N2O is bowel distention,
usually observed when N2O is used as an anesthetic agent. Because
N2O absorbed in the circulation is rapidly eliminated by the lungs,
this appears more to be a theoretical question than a practical
problem.28
The cost of a cylinder of N2O is no different from the cost of a CO2
cylinder. In our operating theatre we have a ceiling tower for central-
ized supplyofN2O andCO2 and it is just a question of toggling a switch
to make the change. In some cases a special connecting cord may be
required. This cord is inexpensive and N2O cylinders are ubiquitous in
operating suites, but one needs to check with the insufﬂator manu-
facturer because some may need to be adjusted for N2O.
In conclusion, the use of N2O as the gas for PP is safe and has
several advantages over CO2, including less postoperative pain,
decreased risk of hemodynamic and cardiovascular side effects as
discussed previously and hence it provides a safe alternative gas for
abdominal insufﬂation in laparoscopic operations.
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